The Experience of Giving Birth With Remifentanil for Pain Relief: A Qualitative Study of Mothers and Midwives
Nordsjaellands Hospital
40 participants
Mar 1, 2025
OBSERVATIONAL
Conditions
Summary
Background: Remifentanil is an ultra-short-acting opioid used for labor pain relief in several countries, offering stronger analgesia than nitrous oxide but less than epidural anesthesia. While internationally established, remifentanil has not yet been implemented in Denmark. Objective: This study aims to explore and deepen our understanding of the childbirth experience with remifentanil for pain relief, from both the birthing woman's and the midwife's perspectives. Methods: A qualitative study based on interviews with women who gave birth using remifentanil and the midwives involved in their care.
Eligibility
Inclusion Criteria2
- Women in labor aged 18 years or older who receive remifentanil for pain relief during childbirth at the labor ward in Hillerød.
- Midwives who participate in childbirths where remifentanil is used as pain relief.
Exclusion Criteria1
- )Women in labor who do not speak Danish or English.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07030777